Selsun

NDA 7936, held by Chattem. Selenium Sulfide.

As of Nov 14, 2026, NDA 7936 (Selsun), held by Chattem, was first approved by FDA on May 17, 1951, with 14 approved supplements and 0 published complete response letters.

First approved: May 17, 1951
Review: Standard
Supplements approved: 14
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 15 submissions below

Date	Submission	Status	Documents
May 17, 1951	Original applicationNew dosage form · Standard review	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Selsun2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · lotion/shampoo;topical	Selenium Sulfide	DiscontinuedReference drug

All 15 submissions, including labeling and manufacturing supplements


Jun 24, 1994	Supplement 20Manufacturing · Standard review	Approved	None posted
Jan 19, 1993	Supplement 19Manufacturing · Standard review	Approved	None posted
May 17, 1988	Supplement 17Manufacturing · Standard review	Approved	None posted
Sep 23, 1983	Supplement 16Labeling	Approved	None posted
Jan 26, 1983	Supplement 14Labeling	Approved	None posted
Sep 15, 1982	Supplement 15Manufacturing · Standard review	Approved	None posted
Jan 9, 1981	Supplement 13Manufacturing · Standard review	Approved	None posted
Jan 16, 1979	Supplement 11Manufacturing · Standard review	Approved	None posted
Jan 15, 1979	Supplement 10Manufacturing · Standard review	Approved	None posted
Sep 19, 1977	Supplement 9Manufacturing · Standard review	Approved	None posted
Mar 7, 1977	Supplement 8Manufacturing · Standard review	Approved	None posted
Mar 7, 1977	Supplement 7Manufacturing · Standard review	Approved	None posted
Nov 29, 1976	Supplement 6Manufacturing · Standard review	Approved	None posted
Jul 1, 1976	Supplement 5Manufacturing · Standard review	Approved	None posted
May 17, 1951	Original applicationNew dosage form · Standard review	Approved	None posted

Identifiers

Application: NDA 7936
Drugs@FDA: Overview at FDA
Company: Chattem, Inc.

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters